Invicorp (Phentolamine Mesilate, Aviptadil)

Phentolamine mesilate blocks alpha‑adrenergic receptors, causing vasodilation of penile tissue. Aviptadil, a synthetic analogue of vasoactive intestinal peptide, raises intracellular cAMP, leading to smooth‑muscle relaxation. Together they increase arterial inflow and reduce venous outflow, supporting erection.

The appropriate dose of Invicorp is determined by the prescribing clinician based on the patient’s condition, response, and safety considerations. Dosage instructions are individualized and should be followed exactly as prescribed.

Invicorp is intended for adult male patients with erectile dysfunction and is not indicated for use in pregnant or breastfeeding individuals. Safety data for these populations are not available, and the product should not be used by women.

To order Invicorp, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Invicorp combines an alpha‑adrenergic antagonist with a vasoactive peptide, offering rapid onset of action via intracavernous injection. Unlike oral PDE5 inhibitors, it acts directly on penile vasculature and can be useful when oral agents are ineffective or contraindicated.

Invicorp should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct light, and avoid freezing. Follow any additional handling instructions provided by the supplier.

Invicorp is administered by a trained healthcare professional as an intracavernous injection directly into the penile tissue. Proper aseptic technique and correct injection site selection are essential to ensure efficacy and minimize adverse effects.

The most serious risks include priapism (prolonged erection lasting more than four hours), severe hypotension, allergic reactions such as anaphylaxis, and cardiovascular events. Immediate medical attention is required if any of these occur.

Invicorp should not be used by patients with known hypersensitivity to phentolamine, aviptadil, or any excipients, those taking nitrates or certain antihypertensive agents, individuals with severe cardiovascular disease, or anyone for whom intracavernous injection is contraindicated.